BioVector? IU-TAB1 人類胸腺腺瘤細胞系 / IU-TAB1 Human Thymoma Cell Line

通用定義 / General Definition:

BioVector? IU-TAB1 是一種源自 A 型胸腺腺瘤（Type A Thymoma）的人類細胞系。胸腺瘤是一種罕見的起源于胸腺上皮細胞的腫瘤，而 BioVector? IU-TAB1 是極少數(shù)可用于此類癌癥研究的體外模型之一。它為研究胸腺上皮腫瘤的遺傳特性、腫瘤微環(huán)境相互作用以及評估新型靶向療法提供了獨特的平臺。

BioVector? IU-TAB1 is a human cell line derived from a Type A thymoma. Thymomas are rare neoplasms originating from the thymic epithelial cells, and BioVector? IU-TAB1 represents one of the few available in vitro models for this cancer type. It provides a unique platform for studying the genetic characteristics of thymic epithelial tumors, tumor microenvironment interactions, and evaluating novel targeted therapies.

BioVector? IU-TAB1 細胞系技術(shù)說明書 (Cell Line Datasheet)

中文版說明書

1. 產(chǎn)品基本信息

• 產(chǎn)品名稱： BioVector? IU-TAB1 人胸腺腺瘤細胞

• 細胞來源： 人類 (Human)

• 組織來源： 胸腺 (Thymus)

• 生長特性： 貼壁生長

• 細胞形態(tài)： 上皮細胞樣/梭形

2. 培養(yǎng)條件

• 基礎(chǔ)培養(yǎng)基： BioVector? RPMI 1640 培養(yǎng)基

• 血清添加： 10% BioVector? 胎牛血清 (FBS)

• 培養(yǎng)環(huán)境： 37°C，5% $CO_2$，飽和濕度

3. 細胞應(yīng)用

• 胸腺上皮腫瘤（TETs）的分子發(fā)病機制研究。

• 針對 A 型胸腺瘤的抗腫瘤藥物篩選與藥效評價。

• 胸腺腫瘤免疫生物學(xué)研究，包括腫瘤細胞與 T 細胞的相互作用。

4. 注意事項

• 稀有性： 作為稀有的胸腺瘤模型，維持其表型穩(wěn)定性至關(guān)重要，建議控制傳代次數(shù)。

• 傳代建議： 建議在細胞達到 80% 左右匯合度時進行傳代。由于該細胞系可能生長緩慢，傳代比例建議初次嘗試 1:2。

English Datasheet

1. General Product Information

• Product Name: BioVector? IU-TAB1 Human Thymoma Cell Line

• Organism: Human

• Tissue Source: Thymus

• Growth Properties: Adherent

• Morphology: Epithelial-like / Spindle-shaped

2. Culture Conditions

• Basal Medium: BioVector? RPMI 1640 Medium

• Serum Supplement: 10% BioVector? Fetal Bovine Serum (FBS)

• Incubation: 37°C, 5% $CO_2$, Saturated Humidity

3. Applications

• Molecular pathogenesis studies of Thymic Epithelial Tumors (TETs).

• Anti-tumor drug screening and efficacy evaluation specifically for Type A thymomas.

• Research on thymic tumor immunobiology, including interactions between tumor cells and T-cells.

4. Key Usage Notes

• Rarity: As a rare thymoma model, maintaining phenotypic stability is critical; it is recommended to limit the number of passages.

• Subculture: It is recommended to subculture when the cell density reaches approximately 80% confluence. Due to its potentially slow growth rate, a starting split ratio of 1:2 is suggested.

Note: BioVector? IU-TAB1 cells should be handled under Biosafety Level 2 (BSL-2) protocols. To ensure consistent experimental results and support the specific nutritional requirements of thymic epithelium, always use BioVector? RPMI 1640 Medium and BioVector? Fetal Bovine Serum.

Supplier生產(chǎn)廠家: BioVector NTCC典型培養(yǎng)物保藏中心

http://www.nedfriskphoto.com

E-mail: [email protected]